Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CNFinance ADR | CNF | Nov 1, 2024 | 1.05 | -1.87 |
CNH Industrial N.V. | CNH | Nov 1, 2024 | 11.26 | +0.27 |
CNO Financial Group | CNO | Nov 1, 2024 | 35.92 | +4.42 |
CNS Pharmaceuticals | CNSP | Nov 1, 2024 | 0.11 | +0.90 |
CNX Resources | CNX | Nov 1, 2024 | 33.94 | -0.26 |
Co-Diagnostics | CODX | Nov 1, 2024 | 1.21 | 0.00 |
Coastal Financial | CCB | Nov 1, 2024 | 63.26 | +0.43 |
Coca-Cola | KO | Nov 1, 2024 | 65.01 | -0.46 |
Coca-Cola Consolidated | COKE | Nov 1, 2024 | 1 134.38 | +0.90 |
Coca-Cola Europacific Partners | CCEP | Nov 1, 2024 | 75.60 | -0.53 |
Coca-Cola FEMSA ADR | KOF | Nov 1, 2024 | 81.33 | -2.45 |
Cocrystal Pharma | COCP | Nov 1, 2024 | 1.73 | -2.26 |
Coda Octopus | CODA | Nov 1, 2024 | 8.51 | -0.23 |
Codere Online Luxembourg | CDRO | Nov 1, 2024 | 7.77 | -1.15 |
Codexis | CDXS | Nov 1, 2024 | 3.50 | +11.47 |
Coeptis Therapeutics | COEP | Nov 1, 2024 | 0.20 | -1.00 |
Coeur Mining | CDE | Nov 1, 2024 | 6.15 | -4.50 |
Coffee Holding Company | JVA | Nov 1, 2024 | 2.99 | -1.32 |
Cogent Biosciences | COGT | Nov 1, 2024 | 11.72 | +2.00 |
Cogent Communications | CCOI | Nov 1, 2024 | 81.61 | +1.68 |
Cognex | CGNX | Nov 1, 2024 | 40.41 | +0.45 |
Cognition Therapeutics | CGTX | Nov 1, 2024 | 0.47 | -0.25 |
Cognizant Technology Solutions A | CTSH | Nov 1, 2024 | 74.61 | +0.03 |
Cognyte Software | CGNT | Nov 1, 2024 | 6.45 | -0.62 |
Cohen & Company | COHN | Nov 1, 2024 | 8.46 | +0.95 |
Cohen & Steers | CNS | Nov 1, 2024 | 98.04 | -0.74 |
Cohen & Steers Closedend Opportunity Fund | FOF | Nov 1, 2024 | 12.84 | +0.55 |
Cohen & Steers Duration Pref and Income Fund | LDP | Nov 1, 2024 | 20.89 | -0.14 |
Cohen & Steers Infrastructure Fund | UTF | Nov 1, 2024 | 25.07 | -0.20 |
Cohen & Steers Qualityome Realty Fund | RQI | Nov 1, 2024 | 13.22 | -1.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.